Celon has been building its manufacturing infrastructure with focus on creating a value chain through integrated manufacturing and quality management systems.

Our existing finished formulation facilities are equipped to manufacture Cytotoxic Oral Solid Dosages (OSD) / Small Volume Parenterals (SVP) and Critical Care Small Volume Parenterals (SVP).

These facilities also support the manufacturing of temperature, light, humidity and atmospheric oxygen sensitive products.

Our API and intermediate facilities are designed to manufacture high potent, Cytotoxic and Critical care products.

To align our manufacturing infrastructure to our growth plans, we have greenfield projects which are currently under commissioning. These world class facilities will offer global edge for Celon in the Hormonal and Oncology spaces.